The increase of apoptosis after MSKE treatment was confirmed with the TUNEL and Annexin V assays, in agreement with previous studies that have shown that MSKE promotes apoptosis in prostate cancer cells [7]. Here, ANXA5 is linked to prostate carcinoma.